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Objectives: The potential high-unintended pregnancy rates have resulted in 
great productivity loss in China. Several contraceptive methods have been intro-
duced by both the providers and the woman themselves to reduce the unintended 
pregnancy rates.A cost-benefit analysis on various hormonal contraceptive meth-
ods was performed in order to provide references for contraception selection in 
China. MethOds: A decision-tree model was used to compare contraception costs 
and effects among different contraceptive methods. All women were classified into 
three contraception profiles (continuation, discontinuation and switch, discontinu-
ation and drop-out).Outcomes included no pregnancy, pregnancy with no birth and 
birth. All the probabilities, medical and medication data in this model were derived 
from the literature and interviews. Results: A comparison of total estimated yearly 
and cumulative costs indicated that contraceptive implants, transdermal contracep-
tive, extended-cycle OC, vaginal ring, and IUD were less costly, less than $281733.7 in 
a three-year study period. While transdermal contraceptive, extended-cycle OC and 
vaginal ring were not available in the Chinese market, contraceptive implants and 
IUD were the only two choices in China with lowest cumulative costs. The further 
cost-benefit analysis also demonstrated contraceptive implants as good value for 
money. Using contraceptive implants were proved to have the lowest cost of preg-
nancy from failure of $839.9, with a total cost of $26814.9, and a benefit-cost ratio of 
2.2, far over 1.0. Sensitivity analysis by tornado diagrams showed that cost of preg-
nancies, age and proportion of discontinuation and switch might have the greatest 
impact on the costs and failure risks of contraceptive implants. cOnclusiOns: In 
order to reduce the unintended pregnancy rates, the implementation of hormonal 
contraception may lead to a benefit in terms of both costs and effects. And among 
all the hormonal contraception in the Chinese market, contraceptive implants tend 
to generate greater economic benefits. Note:1US dollar= 6.46 Chinese yuan.
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Objectives: China is a big country with a large population. Reproductive health 
education is not sufficient for women of childbearing age, which leads to high 
unintended pregnancy (UP) rate. These represent a significant cost to the health care 
system. This study analyzes the epidemiology and productivity loss of unintended 
pregnancy in China. MethOds: The study reviewed published scientific articles and 
policy documents related to unintended pregnancy in China. We retrieved literature 
from Wanfang and PubMed databases, and searched policy documents in websites 
of National Bureau of Statistics and National Center for Women and Children’s 
health, China CDC. Results: Almost 10% of fertile women have UP in China each 
year. There are four different results of UP, including miscarriage, elective abortion, 
ectopic pregnancy and delivery. There are two methods of elective abortion, includ-
ing operation abortion and drug abortion. The costs of operation and drug abortion 
are about US $131.58 and $100.62 in early pregnancy respectively, and $154.80 and 
$464.40 in the second trimester respectively. Drug abortion costs are much more in 
the second trimester because of complications. The incidence of ectopic pregnancy 
is about 4.4%, and there are three therapeutic methods. The costs of laparoscopic 
operation and open abdominal surgery are more than drug conservative treatment. 
The costs are between $309.60 and $1393.19. Delivery has three possibilities. Vaginal 
delivery accounted for 52.6%, and cesarean section accounted for 46.2%. The inci-
dence of premature birth is about 6.36%. Vaginal delivery and cesarean section will 
cost about $387.00 and $619.20 respectively. The costs of premature birth range from 
$928.80 to $1547.99, and the costs will be increased with high likelihood of neonatal 
weight. cOnclusiOns: UP poses a heavy economic burden in China, but the eco-
nomic burden could be reduced if fertile women receive more reproductive health 
education, get appropriate treatment and have periodical prenatal examination.
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Objectives: Rotavirus infection was reported as the major cause of severe diar-
rhea in children under 5-years-old in Indonesia. A low cost rotavirus vaccine to 
protect infants from birth has been developed for developing countries, such as 
Indonesia. This study aims to update our initial analysis on the cost-effectiveness 
of rotavirus vaccination in Indonesia, taking a birth-dose vaccination strategy 
explicitly into account. MethOds: An age-structured cohort model was developed 
for the 2013 Indonesia birth cohort. Applying different rotavirus vaccine efficacies 
for formula-fed and breastfed infants, we compared two vaccination strategies: 
(i) three-dose schedule at 2, 3 and 4 months of age, and (ii) three-dose schedule 
at 0, 1, and 2 months of age. We applied a 5-year-time-horizon with 1 monthly 
analytical cycles for children less than 1 year of age and annually thereafter. 
Also, we used Monte Carlo simulations to examine the economic acceptability 
and affordability of the rotavirus vaccination. Results: Rotavirus vaccination 
would reduce rotavirus-diarrhea cases in children under 5-years-old by 475,806 
and 489,259 cases for the first and second strategies, respectively. Considering 
amarket price of US$ 5 per dose, the Indonesian government would require budg-
ets of US$ 65.0 million and US$ 65.3 million for the first and second strategies, 
respectively.The incremental cost-effectiveness ratios wereUS$ 150 and US$ 146for 
Objectives: To assess and compare the efficacy of atropine and atropine with 
glycopyrrolate combination in organophosphate poisoning. MethOds: A retro-
spective study was conducted in a tertiary care teaching hospital of South India. 
Data was collected retrospectively from medical record section from 2012 to 2013 
in a suitable designed case record form. Data was analysed by using SPSS 20.0 with 
chi-square and one way anova. Results: Total of 199 cases of organophosphate 
poisoning was documented out of which 135(67.8%) were males and 64(32.2%) 
were females. The average age in this group of patients was found to be 34.22 + 
14.26. The average pre-hospitalization period was 1.58 + 2.07 days. Among them 
majority of the cases were suicidal (94.5%). A total of 159 patients received only 
atropine as treatment with an average hospital stay of 12.66 (SD= 11.88) days and 
a mean of 8.71(SD= 10.03) days duration in ICU. Whereas the other 40 patients 
received both atropine and glycopyrrolate as treatment with an average stay of 
15.68 (SD= 12.76) days and a mean of 12.12 (SD= 10.40) days duration in ICU. 
Amongst the 159 patients who received only atropine 40.9% received ventilation 
and for the other 40 who received atropine and gylcopyrrolate only 60% received 
ventilation. Out of the 159 patients who received only atropine 7.6% underwent 
tracheostomy and 25.8% were found to have intermediate syndrome, whereas 
for patients who received both atropine and glycopyrrolate 15.4% underwent tra-
cheostomy and 35% were found to have intermediate syndrome. cOnclusiOns: 
Efficacy of two regimens reveals that atropine was found to be more effective 
when given alone when compared with atropine and glycopyrrolate combination 
in OP poisoning.
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Objectives: To assess the effectiveness of combined biochemical and ultrasound 
screening for chromosomal abnormalities in the first trimester of pregnancy on 
reducing the rate of invasive genetic procedures in a city based population on 
Hungary. MethOds: Previously women aged 35 years or more had access to cho-
rionic villus sampling (CVS) or amniocentesis (AC). A private prenatal diagnostic 
center offered a population based screening protocol irrespective of maternal age. 
Invasive testing was performed for women having a combined risk for fetal ane-
uploidy> 1:250. Total number of 4611 singleton and twin pregnancies in the ges-
tational age of 11+0 and 13+6 weeks were enrolled between November 2010 and 
August 2013. Maternal serum level of pregnancy associated protein-A (PAPP-A) and 
free-beta human chorionic gonadotropin (free β -hCG) were determined by KRYPTOR 
(Brahms-Thermofisher Gmbh, Germany). Results: The screening rate in this city 
based population was 60%. 277 (6,3%) women had a positive first trimester screen-
ing result. There were 16 fetuses with Down’s syndrome and 14 fetuses with other 
chormosomal abnormalities diagnosed. The sensitivity and specificity were 100% 
and 95%, the false positive rate was 4,5% and the false negative rate was 0%. The 
positive predictive value of the test was 11%, the negative predictive value was 100%. 
The number of pregnancies in which an invasive test was performed decreased 
from 518 in 2005 to 295 in 2013, or by 44%. The proportion of women aged less than 
35 years increased, while the rate of women over 35 decreased in this invasive 
group. cOnclusiOns: It is possible to change the pattern of invasive prenatal 
procedures and reduce the proportion of women having CVS or amnio. Efficient 
information is needed to increase the screening rate, especially in a self-financed 
system, where the public health insurance does not cover this type of nationwide 
screening.
PIH8
Burden of dIsease In asIan CountrIes and tHe use of dIsaBIlIty-
adjusted lIfe-years and QualIty-adjusted lIfe-years
Groom Z.C.1, Beale R.C.1, Brooks-Rooney C.2
1Costello Medical Consulting Ltd., Cambridge, UK, 2Costello Medical Singapore Pte Ltd., Singapore
Objectives: Disability-adjusted Life-years (DALYs) and Quality-adjusted Life-
years (QALYs) are two measurements commonly used in health care evaluations; 
however the specific disease areas where they are most applicable are not fully 
defined. The objective of this study was to review the use of DALYs and QALYs in 
trials taking place in China and Thailand and review the relationship with disease 
burden. MethOds: PubMed was searched for studies published after 01/01/2004 
reporting DALYs and QALYs for communicable and non-communicable diseases 
in China and Thailand. Data on disease burden were obtained from the World 
Health Organisation’s (WHO) ‘Mortality and Burden of Disease Estimates for WHO 
Member States in 2004’ database. Results: 117 studies were included for China; 
79 reported QALYs and 38 reported DALYs. 34 studies were included for Thailand 
(QALYs: 28; DALYs: 6). Of trials reporting QALYs, 74.7% of Chinese and 78.6% of 
Thai trials focussed on non-communicable disease; the most commonly investi-
gated disease was cancer. Of trials reporting DALYs, 44.7% of Chinese and 16.7% 
of Thai trials focussed on non-communicable diseases. In terms of the disease 
burden, communicable/non-communicable diseases account for 24.6%/75.4% and 
33.7%/66.3% of the burden in China and Thailand respectively. Leading causes of 
disease burden were cerebrovascular disease (7.7%) and HIV (12.0%) in China and 
Thailand respectively. cOnclusiOns: A dual burden of disease was observed in 
Asian countries in terms of non-communicable/communicable diseases. The QALY 
was the preferred measure for non-communicable diseases in China and Thailand. 
While the DALY is used equally in communicable and non-communicable diseases 
in China, it is used predominantly for non-communicable diseases in Thailand. 
This presents a challenge to health care managers; while it is clear that QALY is 
used mostly for non-communicable diseases, the most appropriate use of the 
DALY is unclear. Further research into the characteristics of diseases within these 
categories is required.
